Suppr超能文献

使用肝脏嵌合人源化小鼠鉴定全氟和多氟烷基物质的人类特异性不良结局途径。

Identifying Human Specific Adverse Outcome Pathways of Per- and Polyfluoroalkyl Substances Using Liver-Chimeric Humanized Mice.

作者信息

Robarts Dakota R, Paine-Cabrera Diego, Kotulkar Manasi, Venneman Kaitlyn K, Gunewardena Sumedha, Corton J Christopher, Lau Christopher, Foquet Lander, Bial Greg, Apte Udayan

机构信息

Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS.

Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS.

出版信息

bioRxiv. 2023 Feb 3:2023.02.01.526711. doi: 10.1101/2023.02.01.526711.

Abstract

BACKGROUND

Per- and polyfluoroalkyl substances (PFAS) are persistent organic pollutants with myriad adverse effects. While perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS) are the most common contaminants, levels of replacement PFAS, such as perfluoro-2-methyl-3-oxahexanoic acid (GenX), are increasing. In rodents, PFOA, PFOS, and GenX have several adverse effects on the liver, including nonalcoholic fatty liver disease.

OBJECTIVE

We aimed to determine human-relevant mechanisms of PFAS induced adverse hepatic effects using FRG liver-chimeric humanized mice with livers repopulated with functional human hepatocytes.

METHODS

Male humanized mice were treated with 0.067 mg/L of PFOA, 0.145 mg/L of PFOS, or 1 mg/L of GenX in drinking water for 28 days. Liver and serum were collected for pathology and clinical chemistry, respectively. RNA-sequencing coupled with pathway analysis was used to determine molecular mechanisms.

RESULTS

PFOS caused a significant decrease in total serum cholesterol and LDL/VLDL, whereas GenX caused a significant elevation in LDL/VLDL with no change in total cholesterol and HDL. PFOA had no significant changes in serum LDL/VLDL and total cholesterol. All three PFAS induced significant hepatocyte proliferation. RNA-sequencing with alignment to the human genome showed a total of 240, 162, and 619 differentially expressed genes after PFOA, PFOS, and GenX exposure, respectively. Upstream regulator analysis revealed inhibition of NR1D1, a transcriptional repressor important in circadian rhythm, as the major common molecular change in all PFAS treatments. PFAS treated mice had significant nuclear localization of NR1D1. modeling showed PFOA, PFOS, and GenX potentially interact with the DNA-binding domain of NR1D1.

DISCUSSION

These data implicate PFAS in circadian rhythm disruption via inhibition of NR1D1. These studies show that FRG humanized mice are a useful tool for studying the adverse outcome pathways of environmental pollutants on human hepatocytes in situ.

摘要

背景

全氟和多氟烷基物质(PFAS)是具有多种不良影响的持久性有机污染物。虽然全氟辛酸(PFOA)和全氟辛烷磺酸(PFOS)是最常见的污染物,但替代PFAS(如全氟-2-甲基-3-氧杂己酸(GenX))的含量正在增加。在啮齿动物中,PFOA、PFOS和GenX对肝脏有多种不良影响,包括非酒精性脂肪性肝病。

目的

我们旨在使用肝脏重新植入功能性人类肝细胞的FRG肝脏嵌合人源化小鼠,确定PFAS诱导肝脏不良影响的与人类相关的机制。

方法

雄性人源化小鼠饮用含0.067 mg/L的PFOA、0.145 mg/L的PFOS或1 mg/L的GenX的水28天。分别收集肝脏和血清进行病理学和临床化学分析。采用RNA测序结合通路分析来确定分子机制。

结果

PFOS导致血清总胆固醇和低密度脂蛋白/极低密度脂蛋白显著降低,而GenX导致低密度脂蛋白/极低密度脂蛋白显著升高,总胆固醇和高密度脂蛋白无变化。PFOA对血清低密度脂蛋白/极低密度脂蛋白和总胆固醇无显著影响。所有三种PFAS均诱导显著的肝细胞增殖。与人类基因组比对的RNA测序显示,PFOA、PFOS和GenX暴露后分别有240、162和619个差异表达基因。上游调节因子分析显示,抑制昼夜节律中重要的转录抑制因子NR1D1是所有PFAS处理中的主要共同分子变化。PFAS处理的小鼠NR1D1有显著的核定位。建模显示PFOA、PFOS和GenX可能与NR1D1的DNA结合结构域相互作用。

讨论

这些数据表明PFAS通过抑制NR1D1扰乱昼夜节律。这些研究表明,FRG人源化小鼠是原位研究环境污染物对人类肝细胞不良结局途径的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7ec/9915685/24d6a16c8df7/nihpp-2023.02.01.526711v1-f0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验